BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2962598)

  • 1. Magnetic resonance imaging in small lesions of the central nervous system. Improvement by gadolinium-DTPA.
    Schroth G; Grodd W; Guhl L; Grauer M; Klose U; Niendorf HP
    Acta Radiol; 1987; 28(6):667-72. PubMed ID: 2962598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nuclear magnetic resonance tomography using gadolinium-DTPA in the diagnosis of spinal lesions].
    Fenzl G; Heywang SH; Vogl T
    Rofo; 1988 Apr; 148(4):415-8. PubMed ID: 2834789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
    Bradac GB; Riva A; Berger T; Stura G; Duca S
    Radiol Med; 1988; 76(1-2):33-7. PubMed ID: 3399707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity].
    Kornienko VN; Pronin IN; Turkin AM; Fadeeva LM
    Zh Vopr Neirokhir Im N N Burdenko; 1993; (4):13-7. PubMed ID: 8296501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of contrast agents in the evaluation of neoplasms of the central nervous system.
    Yuh WT; Fisher DJ; Nguyen HD; Tali ET; Mayr NA
    Top Magn Reson Imaging; 1992 Sep; 4(4):1-6. PubMed ID: 1419031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Gd-DTPA in diseases of the central nervous system.
    Shen TZ; Mei H; Huang XL; Chen XR
    Chin Med J (Engl); 1991 Apr; 104(4):313-20. PubMed ID: 2065550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd DTPA. Clinical efficacy.
    Runge VM; Schaible TF; Goldstein HA; Wood ML; Haughton VM; Maravilla KR; Weinstein MA; Price AC; Wolpert SM; Kaufman D
    Radiographics; 1988 Jan; 8(1):147-59. PubMed ID: 3353531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gadolinium DTPA in a MR study of expansive lesions of the cranial base].
    Bartolozzi C; Olmastroni M; Dal Pozzo G; Petacchi D
    Radiol Med; 1988 Sep; 76(3):152-7. PubMed ID: 3175068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acoustic neurinomas. Magnetic resonance tomography using the contrast medium Gd-DTPA].
    Pronin IN; Kornienko VN
    Zh Vopr Neirokhir Im N N Burdenko; 1995; (2):16-7. PubMed ID: 7625134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MRT of brain metastases. (I) What is the place of screening with T2-weighted sequences?].
    Hosten N; Schörner W; Schubeus P; Felix R
    Rofo; 1990 Sep; 153(3):321-6. PubMed ID: 2171067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
    Haughton VM; Rimm AA; Czervionke LF; Breger RK; Fisher ME; Papke RA; Hendrix LE; Strother CM; Turski PA; Williams AL
    Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of meningeal contrast enhancement on magnetic resonance imaging.
    McKinstry CS; Worthington BS; Niendorf HP; Young IR
    Acta Radiol Suppl; 1986; 369():564-7. PubMed ID: 2980559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
    Mano I; Yoshida H; Kono T; Tsuchida T; Terao H; Iio M
    Rinsho Hoshasen; 1987 Dec; 32(13):1547-53. PubMed ID: 3448287
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular, inflammatory and tumorous lesions of the temporal bone and cerebellopontile angle: applications of magnetic resonance tomography].
    Jäger L; Arnold B; Müller-Lisse U; Grevers G; Reiser M
    Laryngorhinootologie; 1995 Jan; 74(1):57-61. PubMed ID: 7888026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MRI in meningiomas: with and without gadopentetate.
    Wagle VG; Glickstein M
    Conn Med; 1990 Sep; 54(9):485-91. PubMed ID: 2225815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of spinal meningiomas and neurinomas. Improvement of imaging by paramagnetic contrast enhancement.
    Schroth G; Thron A; Guhl L; Voigt K; Niendorf HP; Garces LR
    J Neurosurg; 1987 May; 66(5):695-700. PubMed ID: 3572496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of residual acoustic schwannoma using gadolinium-DTPA enhanced magnetic resonance imaging with the fat suppression technique.
    Battista RA; Bojrab DI; Wang AM
    Am J Otol; 1995 Sep; 16(5):628-33. PubMed ID: 8588668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of intracranial meningioma imaged by magnetic resonance tomography].
    Treisch J; Schörner W; Laniado M; Felix R
    Rofo; 1987 Feb; 146(2):207-14. PubMed ID: 3029837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gd-DTPA-enhanced MR imaging of spinal tumors.
    Parizel PM; Balériaux D; Rodesch G; Segebarth C; Lalmand B; Christophe C; Lemort M; Haesendonck P; Niendorf HP; Flament-Durand J
    AJR Am J Roentgenol; 1989 May; 152(5):1087-96. PubMed ID: 2705343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.